A Hidden Gem of a Book

I haven't had time to sneeze for a long time let alone troll Amazon for new lymphoma book releases. I had found some new books earlier - I've talked about them in previous posts. But this one slipped through.



The Roller Coaster Chronicles is a powerful book providing a goldmine of insights into the experience of healing from the perspective of a lymphoma patient and survivor. Betsy de Parry's story is both humorous and compassionate as she takes an intimate look back at her medical journey and the effect it had on her marriage, self-identity and life perspective. For patients, caregivers and and loved ones this is a very good read.



Back to my time management issues - I finally had to take tomorrow off to get shopping done before Black Friday. Too bad I cannot get the Amazon referral fees from doing my own shopping :-S

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap